A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Nitroxoline
Bupranolol
Sodium phosphate, monobasic may increase the hyperkalemic activities of Bupranolol.
Nitroxoline
Bopindolol
Sodium phosphate, monobasic may increase the hyperkalemic activities of Bopindolol.
Nitroxoline
Tinzaparin
Sodium phosphate, monobasic may increase the hyperkalemic activities of Tinzaparin.
Nitroxoline
Dalteparin
Sodium phosphate, monobasic may increase the hyperkalemic activities of Dalteparin.
Nitroxoline
Ammonium chloride
Sodium phosphate, monobasic may increase the hyperkalemic activities of Ammonium chloride.
Nitroxoline
Danaparoid
Sodium phosphate, monobasic may increase the hyperkalemic activities of Danaparoid.
Nitroxoline
Bufuralol
Sodium phosphate, monobasic may increase the hyperkalemic activities of Bufuralol.
Nitroxoline
Sulodexide
Sodium phosphate, monobasic may increase the hyperkalemic activities of Sulodexide.
Nitroxoline
Nebivolol
Sodium phosphate, monobasic may increase the hyperkalemic activities of Nebivolol.
Nitroxoline
Celiprolol
Sodium phosphate, monobasic may increase the hyperkalemic activities of Celiprolol.
Nitroxoline
Penicillin G Acyl-Serine
Sodium phosphate, monobasic may increase the hyperkalemic activities of Penicillin G Acyl-Serine.
Nitroxoline
Alcuronium
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Alcuronium.
Nitroxoline
Gallamine
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Gallamine.
Nitroxoline
Atracurium
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Atracurium.
Nitroxoline
Hexamethonium
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Hexamethonium.
Nitroxoline
Gantacurium
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Gantacurium.
Nitroxoline
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione.
Nitroxoline
Homatropine
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Homatropine.
Nitroxoline
Aluminium phosphate
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Aluminium phosphate.
Nitroxoline
Calcium silicate
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Calcium silicate.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3